European CHMP adopts positive opinion on new indication for nepafenac (Nevanac)

Source: European Medicines Agency
Area: News
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion on a new indication for nepafenac (Nevanac) as follows:   "Reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients".

Full Story →